Figure 5.
Figure 5. Immunofluorescence staining for detection of CD14+/VEGFR-2+ and CD14+/VEGFR-2- cells after transplantation. Human nucleus antibody stained cells (red) in normal human artery (A) but not in control-injured, sham-transplanted mouse artery (B). (C) Balloon-injured mouse femoral artery showed the localization of transplanted human CD14+/VEGFR-2+ cells on the luminal surface of the seeded artery (red cells, arrows) at 4 weeks. (D) No localization of transplanted CD14+/VEGFR-2- cells was observed at 4 weeks. (E) The endothelial cell phenotype of transplanted human cells was confirmed by double staining with human nucleus antibody and antibodies to VE-cadherin (double-positive cells are stained yellow; arrows). Original magnification, 60 ×.

Immunofluorescence staining for detection of CD14+/VEGFR-2+ and CD14+/VEGFR-2- cells after transplantation. Human nucleus antibody stained cells (red) in normal human artery (A) but not in control-injured, sham-transplanted mouse artery (B). (C) Balloon-injured mouse femoral artery showed the localization of transplanted human CD14+/VEGFR-2+ cells on the luminal surface of the seeded artery (red cells, arrows) at 4 weeks. (D) No localization of transplanted CD14+/VEGFR-2- cells was observed at 4 weeks. (E) The endothelial cell phenotype of transplanted human cells was confirmed by double staining with human nucleus antibody and antibodies to VE-cadherin (double-positive cells are stained yellow; arrows). Original magnification, 60 ×.

Close Modal

or Create an Account

Close Modal
Close Modal